The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities-Reference-Cited by-同舟云学术

The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities

Published:2021-03-22 Issue:5 Volume:73 Page:761-773
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Varela‐Calviño Rubén¹,Rodríguez‐Quiroga Marta²³⁴,Dias Carvalho Patrícia²³,Martins Flavia²³,Serra‐Roma André²³,Vázquez‐Iglesias Lorena⁴,Páez de la Cadena María⁴,Velho Sérgia²³,Cordero Oscar J.¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology University of Santiago de Compostela Santiago de Compostela Spain

2. Institute of Research in Health and Innovation Universidade do Porto Porto Portugal

3. IPATIMUP (Institute of Molecular Pathology and Immunology) University of Porto Porto Portugal

4. Department of Biochemistry Immunology and Genetics, University of Vigo Vigo Spain

Funder

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia

Fundação para a Ciência e a Tecnologia

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iub.2454

Reference80 articles.

1. Metastatic Stem Cells: Sources, Niches, and Vital Pathways

2. DPPIV/CD26: a tumor suppressor or a marker of malignancy?

3. Identification of cancer stem cell markers in human malignant mesothelioma cells

4. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

5. CD26 a cancer stem cell marker and therapeutic target

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities;International Journal of Molecular Sciences;2024-07-05

2. Synergistic Antitumor and Apoptotic Activity of Sitagliptin or Linagliptin Plus Cisplatin Against A549 Lung Cancer Cells (an Invitro Study);Journal of Contemporary Medical Sciences;2024-07-02

3. Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy;Cancers;2024-06-30

4. Advances in prognostic models for osteosarcoma risk;Heliyon;2024-04

5. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer;Drug Repurposing;2024